Polymyxin B inhibits pro-inflammatory effects of E. coli outer membrane vesicles whilst increasing immune cell uptake and clearance

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Bradley Whitehead
  • Fabio Antennuci
  • Anders T. Boysen
  • Peter Nejsum

Polymyxin B (PMB) is a peptide based antibiotic that binds the lipid A moiety of lipopolysaccharide (LPS) with a resultant bactericidal effect. The interaction of PMB with LPS presented on outer membrane vesicles (OMVs) is not fully known, however, a sacrificial role of OMVs in protecting bacterial cells by sequestering PMB has been described. Here we assess the ability of PMB to neutralize the immune-stimulatory properties of OMVs whilst modulating the uptake of OMVs in human immune cells. We show for the first time that PMB increases immune cell uptake of Escherichia coli derived OMVs whilst inhibiting TNF and IL-1β production. Therefore, we present a potential new role for PMB in the neutralization of OMVs via LPS masking and increased immune cell uptake.

OriginalsprogEngelsk
TidsskriftJournal of Antibiotics
Vol/bind76
Sider (fra-til)360–364
ISSN0021-8820
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
This work was supported by the Danish Council for Independent Research (DFF-1032-00242B).

Publisher Copyright:
© 2023, The Author(s), under exclusive licence to the Japan Antibiotics Research Association.

ID: 343298122